
ITMN4077
CAS No. 790305-05-4
ITMN4077( —— )
Catalog No. M24786 CAS No. 790305-05-4
ITMN4077 has antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication with an EC50 of 2.131μM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
![]() ![]() |
10MG | 68 | In Stock |
![]() ![]() |
25MG | 115 | In Stock |
![]() ![]() |
50MG | 173 | In Stock |
![]() ![]() |
100MG | 258 | In Stock |
![]() ![]() |
200MG | 388 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameITMN4077
-
NoteResearch use only, not for human use.
-
Brief DescriptionITMN4077 has antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication with an EC50 of 2.131μM.
-
DescriptionITMN4077 has antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication with an EC50 of 2.131μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
RecptorAntiviral
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number790305-05-4
-
Formula Weight568.68
-
Molecular FormulaC26H40N4O8S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (175.85 mM)
-
SMILESCC(C)(C)OC(N[C@@H](CCCCC/C=C\[C@H](C1)[C@]1(C(NS(C1CC1)(=O)=O)=O)NC([C@H](C1)N2C[C@@H]1O)=O)C2=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Pipequaline hydrochl...
Pipequaline is an anticonflict & anticonvulsant quinoline derivative. It is an anxiolytic drug that was never marketed.
-
Antiviral agent 34
Antiviral agent 34 is an orally available, potent antiviral compound that inhibits influenza A and B viruses.
-
BIT225
BIT225 is a human immunodeficiency virus type 1 Vpu inhibitor with antiviral activity that inhibits HIV-1 replication in bone marrow dendritic cells and inhibits ion channels formed by HIV-1 Vpu.